Nutrien (NYSE:NTR) had its target price raised by equities researchers at Credit Suisse Group from $51.00 to $53.00 in a research report issued to clients and investors on Thursday. The brokerage currently has a "neutral" rating on the stock. Credit Suisse Group's target price would indicate a potential downside of 6.11% from the stock's previous close.
Several other analysts also recently commented on the stock. JPMorgan Chase & Co. raised their price objective on shares of Nutrien from $45.00 to $63.00 and gave the stock an "overweight" rating in a research report on Friday, February 19th. TheStreet upgraded Nutrien from a "d+" rating to a "c-" rating in a report on Friday, December 18th. Atlantic Securities cut Nutrien from a "neutral" rating to an "underweight" rating in a report on Tuesday, January 12th. Raymond James set a $65.00 target price on Nutrien and gave the stock a "strong-buy" rating in a report on Friday, February 19th. Finally, Royal Bank of Canada increased their target price on Nutrien from $55.00 to $57.00 and gave the stock an "outperform" rating in a report on Friday, January 15th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company's stock. Nutrien presently has a consensus rating of "Buy" and a consensus price target of $52.79.
NYSE:NTR traded down $0.06 on Thursday, reaching $56.45. 47,808 shares of the stock traded hands, compared to its average volume of 2,071,774. The firm has a market capitalization of $32.14 billion, a price-to-earnings ratio of 334.00, a price-to-earnings-growth ratio of 3.01 and a beta of 0.90. The company's 50 day moving average is $53.40 and its 200-day moving average is $45.12. The company has a current ratio of 1.39, a quick ratio of 0.85 and a debt-to-equity ratio of 0.46. Nutrien has a 1-year low of $23.85 and a 1-year high of $57.73.
Nutrien (NYSE:NTR) last released its earnings results on Wednesday, February 17th. The company reported $0.24 earnings per share for the quarter, beating analysts' consensus estimates of $0.15 by $0.09. Nutrien had a net margin of 0.47% and a return on equity of 4.19%. On average, equities research analysts forecast that Nutrien will post 1.7 EPS for the current fiscal year.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. DORCHESTER WEALTH MANAGEMENT Co raised its stake in shares of Nutrien by 1.9% during the 4th quarter. DORCHESTER WEALTH MANAGEMENT Co now owns 12,196 shares of the company's stock worth $587,000 after purchasing an additional 225 shares during the period. Point View Wealth Management Inc. raised its stake in shares of Nutrien by 1.4% during the 4th quarter. Point View Wealth Management Inc. now owns 20,595 shares of the company's stock worth $992,000 after purchasing an additional 277 shares during the period. Fifth Third Bancorp raised its stake in shares of Nutrien by 39.2% during the 3rd quarter. Fifth Third Bancorp now owns 1,001 shares of the company's stock worth $39,000 after purchasing an additional 282 shares during the period. Mariner LLC raised its stake in shares of Nutrien by 2.6% during the 4th quarter. Mariner LLC now owns 12,872 shares of the company's stock worth $620,000 after purchasing an additional 323 shares during the period. Finally, CWM LLC raised its stake in shares of Nutrien by 95.4% during the 4th quarter. CWM LLC now owns 801 shares of the company's stock worth $39,000 after purchasing an additional 391 shares during the period. Institutional investors own 61.86% of the company's stock.
Nutrien Company Profile
Nutrien Ltd. provides crop inputs and services. The company offers potash, nitrogen, phosphate, and sulfate products. It also distributes crop nutrients, crop protection products, seeds, and merchandise products through operating approximately 2,000 retail locations. The company was incorporated in 2017 and is headquartered in Saskatoon, Canada.
Recommended Story: Dividend Stocks - Are They Right For You?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected]
15 Stocks that Insiders Love
An insider trade occurs when a corporate executive (such as a CEO, CFO or COO) that has non-public information about a company buys or sells shares of that company's stock. Company insiders are required by law to regularly report their stock purchases and sales to the SEC.
Tracking a company's insider trades is a metric that can be used to identify the direction that the company's executives believes that the company is headed. If a number of insiders purchase more shares of their company, they may believe that the company will have strong future earnings and that the share price will increase in the near future.
For example, if Microsoft's CEO, CFO and COO all recently purchased additional shares of Microsoft stock, that would be an indication that there could be unreported news that may positively effect Microsoft's stock price in the near future.
This slideshow lists the 15 companies that have had the highest levels of insider buying within the last 180 days.
View the "15 Stocks that Insiders Love".